- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00767169
Bisphosphonate-coated Dental Implants
December 9, 2013 updated by: Per Aspenberg, University Hospital, Linkoeping
Dental implants (screws for fastening false teeth) have been coated with bisphosphonates (drugs that slow down removal of bone).
Patients get one such screw and one without coating, by a surgeon who does not know which is which.
The screws are compared by measuring how well fixed they are by a vibration measuring technique, and x-rays.
The hypothesis is that the bisphosphonates will improve fixation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Linköping, Sweden, SE-581 85
- Department of Oral & maxillofacial surgery, University Hospital.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Need for at least 2 dental implants, which are to be inserted in bone of reasonably similar quality.
Exclusion Criteria:
- Systemic or immunologic disease, alcoholism, uncontrolled diabetes and smoking.
- Local exclusion criteria were: previous tumour, trauma and surgery.
- Also patients with Cawood & Howell class IV - VI maxilla-bone were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: coated implant and control
|
Dental implant coating with a fibrinogen carrier for pamidronate and ibandronate compared with uncoated controls in the same mouth.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Increase in resonance vibration frequency (ISQ units) from insertion to abutment connection as compared to the control in the same patient.
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Marginal resorption on x-rays
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Per Aspenberg, MD, PhD, Linkoeping University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
October 3, 2008
First Submitted That Met QC Criteria
October 3, 2008
First Posted (Estimate)
October 6, 2008
Study Record Updates
Last Update Posted (Estimate)
December 10, 2013
Last Update Submitted That Met QC Criteria
December 9, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Tandskruv1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental implant coating with a fibrinogen carrier for pamidronate and ibandronate
-
Hadassah Medical OrganizationCompleted
-
Insmed IncorporatedCompletedPseudomonas Aeruginosa InfectionFrance, Poland, United Kingdom, Germany, Spain, Belgium, Bulgaria, Denmark, Greece, Canada, Netherlands, Hungary, Italy, Ireland, Sweden, Slovakia, Austria, Serbia